1. Home
  2. VRA vs CNTB Comparison

VRA vs CNTB Comparison

Compare VRA & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

SELL

Current Price

$7.53

Market Cap

156.6M

ML Signal

SELL

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

HOLD

Current Price

$0.78

Market Cap

140.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
CNTB
Founded
1982
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
156.6M
140.4M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
VRA
CNTB
Price
$7.53
$0.78
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $6.00
AVG Volume (30 Days)
474.4K
★ 1.0M
Earning Date
12-10-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 20.47
N/A
EPS
★ N/A
N/A
Revenue
★ $416,097,000.00
$64,000.00
Revenue This Year
N/A
$11,287.85
Revenue Next Year
$3.56
$74.11
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.39
$0.73
52 Week High
$7.13
$3.82

Technical Indicators

Market Signals
Indicator
VRA
CNTB
Relative Strength Index (RSI) 81.50 35.59
Support Level $3.05 $0.73
Resistance Level N/A $2.62
Average True Range (ATR) 0.35 0.06
MACD 0.03 0.03
Stochastic Oscillator 90.97 9.31

Price Performance

Historical Comparison
VRA
CNTB

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, luggage, and travel items, fashion and home accessories, and gifts. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct and Vera Bradley Indirect.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Share on Social Networks: